Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Income-Applicable-To-Common-Shares" stands at 295.87 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 03/31/2016.
Daiichi Sankyo Co. Ltd.'s first quarter result of 85.50 Billion JPY for the item "Net Income Applicable To Common Shares" represents a decrease of -1.90 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 85.50 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 0.14 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 295.87 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 0.04 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 66.77 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 66.77 Billion Japanese Yens.
The 3 year change is 245.27 Billion Japanese Yens.
The 5 year change is 178.29 Billion Japanese Yens.
The 10 year change is -41.19 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income Applicable To Common Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income Applicable To Common Shares | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income Applicable To Common Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income Applicable To Common Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income Applicable To Common Shares | 280,205,508,085.11 |